Financhill
Back

Palisade Bio Stock Predictions

Palisade Bio Stock Forecast

  • Is Palisade Bio Stock Undervalued?
    The current Palisade Bio [PALI] share price is $2.44. The Score for PALI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Palisade Bio Stock Go Up Next Year?

Data Unavailable

Palisade Bio Stock Rating

Data Unavailable

Palisade Bio Stock Price History

Is PALI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
palisadebio.com

52-Week Data

52-Week High:
22.35
52-Week Low:
2.18

Prediction Charts

Market Cap:
3.73M
Price in USD:
2.44
Volume:
255.78K
Beta:
1.35

Technical Analysis

SMA50:
3.26
SMA100:
3.58
SMA200:
4.64
52-Wk Change:
-72.89%

Stock Predictions

  • Is Palisade Bio stock public?
    Yes, Palisade Bio is a publicly traded company.
  • What is the Palisade Bio stock quote today?
    The Palisade Bio stock price is 2.44 USD today.
  • How to buy Palisade Bio stock online?
    You can buy Palisade Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 2.57 2.77 2.83 2.57
Nov-4 2.72 2.78 2.91 2.58
Nov-5 2.82 2.84 3.22 2.72
Nov-6 2.84 2.55 2.89 2.55
Nov-7 2.64 2.54 2.64 2.43
Nov-8 2.63 2.54 2.71 2.49
Nov-11 2.53 2.49 2.59 2.48
Nov-12 2.48 2.30 2.51 2.30
Nov-13 2.46 2.20 2.46 2.20
Nov-14 2.22 2.62 2.63 2.21
Nov-15 2.63 2.52 2.63 2.35
Nov-18 2.67 2.39 2.67 2.33
Nov-19 2.41 2.43 2.52 2.34
Nov-20 2.43 2.44 2.89 2.35

Palisade Bio Earnings

Data Unavailable

Palisade Bio Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.15 per share, and an increase next year of $8.16 per share.

* Palisade Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.